Long-Acting Opioid Treatment Could Be Available In A Month

Posted by:

National Public Radio : FDA recently announced the approval of Probuphine, an implantable form of buprenorphine, for treating opioid dependence. National Public Radio sought the views of Dr. Cidambi, addiction expert and medical director of the Center for Network Therapy, on the medication.


About the Author:

New Jersey's premier addiction treatment center, offering medically managed detox and rehabilitation treatment programs.
  Related Posts

Add a Comment